Provided By Globe Newswire
Last update: Apr 25, 2022
– Company advancing development of its Autoimmunity Modifying AIM Biologicals as a potential therapeutic treatment option for Parkinson’s Disease ("PD"), a neurodegenerative movement disorder
Read more at globenewswire.com